Andrew Emili, PhD
Professor
Boston University College of Arts and Sciences
Dept of Biology

PhD, University of Toronto
MS, University of Toronto




Systems Biology
Molecular / Protein Interaction Networks
Mass Spectrometry
Molecular Genetics/Genomics, Proteomics, Biochemistry, Bioinformatics

Professor
Boston University School of Medicine
Biochemistry


Founding Professor
Boston University School of Medicine, Graduate Medical Sciences
Computing & Data Sciences Administration


Graduate Faculty (Primary Mentor of Grad Students)
Boston University School of Medicine, Graduate Medical Sciences


Member
Boston University
Genome Science Institute



2007 Heart & Stroke/Lewar Centre Excellence, University of Toronto: Subash Verma Research Award
1997-2000 Damon Runyon Cancer Research Foundation, USA: Cancer Research Fellow
1991-1997 Medical Research Council, Canada: Graduate Fellowships
1990 McGill University, QC Canada: Summa Cum Laude


Mapping Protein Interaction Networks Essential for Gonococcal Pathogenesis
05/06/2021 - 04/30/2026 (PI)
NIH/National Institute of Allergy & Infectious Diseases
1R01AI146941-01A1

Multiscale analysis of metabolic inflammation as a driver of breast cancer
09/09/2020 - 08/31/2025 (Multi-PI)
PI: Andrew Emili, PhD
NIH/National Cancer Institute
5U01CA243004-02

Genetic Modifiers of Protein Interaction Networks in Tauopathy
08/01/2019 - 03/31/2024 (Multi-PI)
PI: Andrew Emili, PhD
NIH/National Institute on Aging
5R01AG064932-03

Systems-level functional proteomics analysis assemblies in Alzheimer's disease and mouse models of tauopathy
02/15/2019 - 01/31/2024 (Multi-PI)
PI: Andrew Emili, PhD
NIH/National Institute on Aging
1RF1AG061706-01

RAPID: Transcription Factor Profiling for SARS-CoV2 Tolerance/Symbiosis Regulation
06/01/2020 - 05/31/2022 (Multi-PI)
PI: Andrew Emili, PhD
National Science Foundation
IOS-2031624

Mapping Pathogenic Coronavirus Viral-Host Protein Interaction Environments for Target Discovery
08/03/2020 - 01/02/2022 (Multi-PI)
PI: Andrew Emili, PhD
Merck, Sharp & Dohme Corp


A new human iPSC in vitro system to model the inception of lung adenocarcinoma (2nd Year Renewal - WWDA)
12/01/2020 - 12/31/2021 (Multi-PI)
PI: Andrew Emili, PhD
Janssen Research & Development, LLC


Engineering a smart CAR platform for human regulatory T cells
09/30/2019 - 09/29/2021 (Co-Investigator)
NIH/National Institute of Biomedical Imaging & Bioengineering
1R56EB027729-01A1

Ultra-High Precision Mass Spectrometer
07/01/2020 - 06/30/2021 (PI)
NIH/Office of the Director
1S10OD026807-01A1

A new human iPSC in vitro system to model the inception of lung adenocarcinoma
06/01/2020 - 11/30/2020 (Multi-PI)
PI: Andrew Emili, PhD
Johnson & Johnson Enterprise Innovation, Inc.


Showing 10 of 13 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Blum BC, Lin W, Lawton ML, Liu Q, Kwan J, Turcinovic I, Hekman R, Hu P, Emili A. Multiomic Metabolic Enrichment Network Analysis Reveals Metabolite-Protein Physical Interaction Subnetworks Altered in Cancer. Mol Cell Proteomics. 2022 Jan; 21(1):100189.View Related Profiles. PMID: 34933084
     
  2. Moore J, Emili A. Mass-Spectrometry-Based Functional Proteomic and Phosphoproteomic Technologies and Their Application for Analyzing Ex Vivo and In Vitro Models of Hypertrophic Cardiomyopathy. Int J Mol Sci. 2021 Dec 20; 22(24). PMID: 34948439
     
  3. Miles A, Blair C, Emili A, Tropepe V. Usher syndrome type 1-associated gene, pcdh15b, is required for photoreceptor structural integrity in zebrafish. Dis Model Mech. 2021 12 01; 14(12). PMID: 34668518; PMCID: PMC8669488; DOI: 10.1242/dmm.048965;
     
  4. Lawton ML, Emili A. Mass Spectrometry-Based Phosphoproteomics and Systems Biology: Approaches to Study T Lymphocyte Activation and Exhaustion. J Mol Biol. 2021 12 03; 433(24):167318. PMID: 34687714
     
  5. Zhang Z, Na H, Gan Q, Tao Q, Alekseyev Y, Hu J, Yan Z, Yang JB, Tian H, Zhu S, Li Q, Rajab IM, Blusztajn JK, Wolozin B, Emili A, Zhang X, Stein T, Potempa LA, Qiu WQ. Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: A risk factor for Alzheimer's disease? Aging Cell. 2021 11; 20(11):e13501.View Related Profiles. PMID: 34687487; PMCID: PMC8590103; DOI: 10.1111/acel.13501;
     
  6. Rabhi N, Desevin K, Cortez BN, Hekman R, Lin JZ, Emili A, Farmer SR. The cyclin dependent kinase inhibitor Roscovitine prevents diet-induced metabolic disruption in obese mice. Sci Rep. 2021 10 13; 11(1):20365.View Related Profiles. PMID: 34645915; PMCID: PMC8514475; DOI: 10.1038/s41598-021-99871-z;
     
  7. Chen DY, Khan N, Close BJ, Goel RK, Blum B, Tavares AH, Kenney D, Conway HL, Ewoldt JK, Chitalia VC, Crossland NA, Chen CS, Kotton DN, Baker SC, Fuchs SY, Connor JH, Douam F, Emili A, Saeed M. SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway. J Virol. 2021 09 09; 95(19):e0086221.View Related Profiles. PMID: 34260266; PMCID: PMC8428404; DOI: 10.1128/JVI.00862-21;
     
  8. Muraoka S, Lin W, Takamatsu-Yukawa K, Hu J, Ikezu S, DeTure MA, Dickson DW, Emili A, Ikezu T. Enrichment of Phosphorylated Tau (Thr181) and Functionally Interacting Molecules in Chronic Traumatic Encephalopathy Brain-derived Extracellular Vesicles. Aging Dis. 2021 Sep; 12(6):1376-1388.View Related Profiles. PMID: 34527416; PMCID: PMC8407888; DOI: 10.14336/AD.2020.1007;
     
  9. Alysandratos KD, Russo SJ, Petcherski A, Taddeo EP, Acín-Pérez R, Villacorta-Martin C, Jean JC, Mulugeta S, Rodriguez LR, Blum BC, Hekman RM, Hix OT, Minakin K, Vedaie M, Kook S, Tilston-Lunel AM, Varelas X, Wambach JA, Cole FS, Hamvas A, Young LR, Liesa M, Emili A, Guttentag SH, Shirihai OS, Beers MF, Kotton DN. Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease. Cell Rep. 2021 08 31; 36(9):109636.View Related Profiles. PMID: 34469722; PMCID: PMC8432578; DOI: 10.1016/j.celrep.2021.109636;
     
  10. Jiang L, Lin W, Zhang C, Ash PEA, Verma M, Kwan J, van Vliet E, Yang Z, Cruz AL, Boudeau S, Maziuk BF, Lei S, Song J, Alvarez VE, Hovde S, Abisambra JF, Kuo MH, Kanaan N, Murray ME, Crary JF, Zhao J, Cheng JX, Petrucelli L, Li H, Emili A, Wolozin B. Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy. Mol Cell. 2021 10 21; 81(20):4209-4227.e12.View Related Profiles. PMID: 34453888; PMCID: PMC8541906; DOI: 10.1016/j.molcel.2021.07.038;
     
Showing 10 of 235 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 235 publications over 22 distinct years, with a maximum of 22 publications in 2005

YearPublications
19981
20001
20024
200311
200411
200522
200610
200718
200811
200912
201013
20119
201213
201313
201413
20159
201610
201710
20184
20197
202017
202116
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Systems Biology
Molecular / Protein Interaction Networks
Mass Spectrometry
Molecular Genetics/Genomics
Proteomics
Biochemistry
Bioinformatics

Available to Mentor as: (Review Mentor Role Definitions):
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

72 E. Concord Street
Boston MA 02215
Google Map


Emili's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department